Skip to content

Featured Articles

CVS recognized as Health Care Provider of the Year

CVS recognized as Health Care Provider of the Year

The future of health care in this country will center on ecosystems that span the continuum of care. A number of entities, including companies with roots in chain pharmacy, are in the process of altering their business model to align with the new paradigm. None of them is further along in assembling

WBA’s first quarter earnings beat estimates

WBA’s first quarter earnings beat estimates

Walgreens Boots Alliance posted first quarter sales and earnings that topped analysts’ forecasts. WBA reported adjusted earnings per share of $1.16, surpassing the expected $1.14. Revenue for the three-month period ended Nov. 30 was $33.38 billion, ahead of the projected $32.84 billion.

Rite Aid Q3 results beat expectations

Rite Aid Q3 results beat expectations

Rite Aid Corp. Thursday reported better-than-expected third quarter sales and earnings. The company also narrowed its fiscal 2020 earnings forecast while maintaining its revenue guidance. The results lifted the retailer’s shares more than 20% to over $10.

NRF report says Super Saturday will be huge

NRF report says Super Saturday will be huge

The Saturday before Christmas continues to be the biggest shopping day of the year, according to survey results released  by the National Retail Federation and Prosper Insights & Analytics, which estimates that 147.8 million U.S. consumers are expected to participate this year, up from 134.

EnvisionRxOptions names Robson president

EnvisionRxOptions names Robson president

CAMP HILL, Pa. – EnvisionRxOptions, a wholly-owned subsidiary of Rite Aid and a leading pharmacy services and benefits company, announced Monday the appointment of Dan Robson as the company’s president. Robson will lead all aspects of EnvisionRxOptions operations.

Pharmacy coalition applauds drug pricing act

Pharmacy coalition applauds drug pricing act

A coalition of national pharmacy groups on Tuesday applauded the latest version of the bipartisan Prescription Drug Pricing Reduction Act, released Friday by the Senate Finance Committee, which they say addresses backdoor clawback fees charged by large pharmacy benefit managers (PBMs) that are shutt